Doença de Horton – a propósito de 40 casos
Palavras-chave:
arterite, Horton, manifestações atípicas, corticoidesResumo
Apresentamos uma casuística de 40 casos de
Doença de Horton observados no Serviço de Medicina 2 e na Consulta de Doenças Autoimunes
do Hospital de Santo António dos Capuchos, entre 1984 e 2002.
Pretendemos comentar e destacar os aspectos
práticos, clínicos, de diagnóstico e de terapêutica, relacionados com o adequado controle
da doença, através da análise comparativa da literatura com os nossos dados.
Downloads
Referências
Cormier J, Cormier F, Laridon D, Vuong P. Maladie de Horton et aneurisme aortique: coincidence ou association? Cinq observations. J
Mal Vasc 2000; 25(2): 92-97.
Evans J, O’Fallon W, Hunder G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based
study. Ann Intern Med 1995; 122(7): 502-507.
Hunder G, Bloch D, Michel B et al. The American College of Rheumatology 1990 criteria for the classification of Giant Cell Arteritis.
Arthritis Rheum 1990; 33: 1122-1128.
Cunha R, Horta A, Goes MJ, Castro S. Arterite de células gigantes (Doença de Horton): a propósito de 18 casos. Acta Méd Port 1993;
(2): 83-85.
Hazleman B. Polymyalgia rheumatica and giant cell arteritis. In. Klippel J, Dieppe P, eds. Rheumatology. Ed. Mosby. Second edition 2000; 7:
1–21.8.
Salvarani C, Cantini F, Boiardi L, Hunder G. Polymialgia Rheumatica and Giant-Cell Arteritis. NEJM 2002; 347(4): 261-271.
Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann
Intern Med 1978; 88(2): 162-167.
Becourt-Verlomme C, Barouky R, Alexandre C, Gonthier R, Laurent H, Vital Durant D, Rousset H. Symptomes inauguraux de la maladie
de Horton sur une série de 260 patients. Rev Med Interne 2001; 22(7): 631-637.
Dot C, Hamard P, Metge F, Hamard H. Neuropathie optique ischémique aigüe bilateralisée em 3 jours dans le cadre d’une maladie de Horton. J Fr Ophtalmol 2001; 24(8): 860-864.
Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981; 24(11):
-1418.
Larson TS, Hall S, Hepper NG, Hunder GG. Respiratory tract symptoms as a clue to giant cell arteritis. Ann Intern Med 1984; 101(5):
-597.
Healey L, Wilske. Anemia as a presenting manifestation of giant cell arteritis. Arthritis Rheum 1971; 14: 27-31.
Salvarani C, Macchioni PL, Tartoni PL et al. Polymialgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987; 5: 205-215.
Kattah J, Cupps T, Manz H et al. Occipital artery biopsy: a diagnostic alternative in giant-cell arteritis. Neurol 1991; 41: 949-950.
Calamia KT, Hunder GG. Clinical manifestations of giant cell (temporal) arteritis. Clin Rheum Dis 1980; 6: 389-403.
Cunha R, Castro A. Maladie de Horton formes de présentation sistémique. A propôs de quatre observations. Med et Hyg 1992; 50:
-852.
Paulley JW, Hughes JP. Giant-cell arteritis, or arteritis of the aged. BMJ 1960; 2: 1562-1567.
Salvarani C, Hunder GG. Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis. Arthritis Rheum
; 42(6): 1259-1266.
Serratrice G. Le diagnostique des myalgies après effort. Concours Med 1989; 111: 2552-2558.
Saadoun D, Cacoub P, Costedoat-Chalumeau N, Sbai A, Piette JC. Maladie de Horton et surdité cortico-sensible. Ann Med Intern (Paris)
; 151(7): 600-602.
Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis:
predictors and response to treatment. Arthritis Rheum 1998; 41(8): 1497-504.
Caselli RJ, Daube JR, Hunder GG, Whisnant JP. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology 1988; 38(5):
-689.
Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based
study. Arthritis Rheum 2001; 45(2): 140-145.
Cantini F, Salvarani C, Olivieri I et al. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymialgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum 2000; 30: 17-24.
Achkar AA, Lie JT, Hunder GG, O´Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell
(temporal) arteritis? Ann Intern Med 1994; 120(12): 987-992.
Schmidt W, Kraft H, Vorpahl K, Völker L, Gromnica-Ihle E. Color duplex ultrasonography in the diagnosis of temporal arteritis. NEJM
; 337(19): 1336-1342.
Nesher G, Sonnenblick M, Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of
patients. J Rheumatol 1994; 21(7): 1283-1286.
Chevalet P, Masseau-Imbert A, Durant-Fix MH et al. Maladie de Horton chez le sujet agê de plus de 75 ans. Ann Med Interne (Paris)
; 153(6): 373-377.
Sailler L, Carreiro M, Ollier S. Maladie de Horton non compliquée: traitement initial par trois bolus de 500 mg de méthylprednisolone suivis
de 20 mg/j d´équivalent-prednisone. Évaluation chez 15 patients. Rev Med Interne 2001; 22: 1032-1038
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
